High-Dose Ara-C as a Single-Agent Consolidation Therapy in Childhood Acute Myelogenous Leukemia
- 1 January 1990
- book chapter
- Published by Springer Nature
- Vol. 33, 215-221
- https://doi.org/10.1007/978-3-642-74643-7_39
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Population‐Based Study of Childhood Acute Lymphoblastic Leukemia Diagnosed from July 1981 through June 1985 in the Five Nordic CountriesActa Paediatrica, 1987
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Preleukaemic states in childrenScandinavian Journal of Haematology, 1986
- Myelodysplastic syndromes in childhood: three case reportsBritish Journal of Haematology, 1985
- Vitamin A and/or high‐dose Ara‐C in the maintenance of remission in acute myelogenous leukaemia in children?Scandinavian Journal of Haematology, 1984
- Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study GroupThe Journal of Pediatrics, 1984
- Cytarabine: Low-Dose, High-Dose, No Dose?New England Journal of Medicine, 1983
- Hematopoietic dysplasia and marrow hypocellularity in children: A preleukemic conditionThe Journal of Pediatrics, 1982
- Preleukemia in childrenThe Journal of Pediatrics, 1981